Researchers identified gut microbiota signatures and developed a microbial age metric, demonstrating that a younger microbial age may reduce cardiovascular disease (CVD) risk in metabolically unhealthy older adults.
Pfizer’s alopecia tablet approved by FDA in adults and teens, winning broader market than Lilly’s Olumiant
The FDA has given a thumbs-up to the first treatment option for adolescents with alopecia areata, an autoimmune disease that leads to hair loss. The
June 27, 2023